Biodesix (BDSX) Payables (2019 - 2025)
Historic Payables for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $3.6 million.
- Biodesix's Payables rose 4138.74% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 4138.74%. This contributed to the annual value of $2.2 million for FY2024, which is 2567.11% down from last year.
- Latest data reveals that Biodesix reported Payables of $3.6 million as of Q3 2025, which was up 4138.74% from $3.0 million recorded in Q2 2025.
- In the past 5 years, Biodesix's Payables registered a high of $16.4 million during Q3 2022, and its lowest value of $1.6 million during Q1 2023.
- Over the past 5 years, Biodesix's median Payables value was $3.0 million (recorded in 2023), while the average stood at $4.2 million.
- Per our database at Business Quant, Biodesix's Payables crashed by 9461.53% in 2021 and then skyrocketed by 91444.44% in 2022.
- Quarter analysis of 5 years shows Biodesix's Payables stood at $1.7 million in 2021, then increased by 3.15% to $1.7 million in 2022, then soared by 71.86% to $3.0 million in 2023, then decreased by 25.67% to $2.2 million in 2024, then soared by 63.79% to $3.6 million in 2025.
- Its Payables was $3.6 million in Q3 2025, compared to $3.0 million in Q2 2025 and $2.9 million in Q1 2025.